

| 规格 | 价格 | 会员价 | 库存 | 数量 | |||
|---|---|---|---|---|---|---|---|
| {[ item.pr_size ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate,item.mem_isinteger) ]} | 现货 | 1周 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解

| 产品名称 | GSK-3 ↓ ↑ | GSK-3α ↓ ↑ | GSK-3β ↓ ↑ | 其他靶点 | 纯度 | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| AZD2858 |
+
GSK-3, IC50: 68 nM |
99% | |||||||||||||||||
| Bikinin | ✔ | 99%+ | |||||||||||||||||
| GSK 3 Inhibitor IX |
++++
GSK-3, IC50: 5 nM |
99%+ | |||||||||||||||||
| AZD1080 |
+++
GSK-3α, IC50: 6.9 nM |
++
GSK-3β, IC50: 31 nM |
99%+ | ||||||||||||||||
| BIO-acetoxime |
+++
GSK-3α, IC50: 10 nM |
+++
GSK-3β, IC50: 10 nM |
95% | ||||||||||||||||
| SB-216763 |
++
GSK-3α, IC50: 34.3 nM |
++
GSK-3β, IC50: ~34.3 nM |
98% | ||||||||||||||||
| SB 415286 |
+
GSK-3α, IC50: 78 nM |
+
GSK-3β, IC50: ~78 nM |
99%+ | ||||||||||||||||
| CHIR-98014 |
++++
GSK-3α, IC50: 0.65 nM |
++++
GSK-3β, IC50: 0.58 nM |
98% | ||||||||||||||||
| LY2090314 |
++++
GSK-3α, IC50: 1.5 nM |
++++
GSK-3β, IC50: 0.9 nM |
99%+ | ||||||||||||||||
| CHIR 99021 |
+++
GSK-3α, IC50: 10 nM |
++++
GSK-3β, IC50: 6.7 nM |
99%+ | ||||||||||||||||
| TDZD-8 |
+
GSK-3β, IC50: 2 μM |
99%+ | |||||||||||||||||
| Indirubin |
+
GSK-3β, IC50: 0.6 μM |
98% | |||||||||||||||||
| IM-12 |
++
GSK-3β, IC50: 53 nM |
98% | |||||||||||||||||
| TWS119 |
++
GSK-3β, IC50: 30 nM |
99% | |||||||||||||||||
| 1-Azakenpaullone |
+++
GSK-3β, IC50: 18 nM |
99%+ | |||||||||||||||||
| AR-A014418 |
++
GSK-3β, Ki: 38 nM |
99%+ | |||||||||||||||||
| Tideglusib |
+
GSK-3β, IC50: 60 nM |
98% | |||||||||||||||||
| 1. 鼠标悬停在“+”上可以显示相关IC50的具体数值。"+"越多,抑制作用越强。2. "✔"表示该化合物对相应的亚型有抑制作用,但抑制强度暂时没有相关数据。 | |||||||||||||||||||
| 靶点 |
|
| 描述 | Glycogen synthase kinase-3 (GSK-3) is a serine/threonine kinase involved in cell differentiation, cellular growth and proliferation, apoptosis, and inflammation. There are two isoforms of GSK-3, GSK-3α and GSK-3β. 1-Azakenpaullone is a potent inhibitor of GSK-3β with an IC50 value of 18 nM. In contrast, the IC50 values of 1-Azakenpaullone against CDK1/cycline B and CDK5/p25 were 2.0 and 4.2 μM, respectively[3]. 1-Azakenpaullone at the concentrations of 5, 10, and 15 μM significantly promoted DNA synthesis in human pancreatic islets above the levels at 8 mM glucose. Exposure of human pancreatic islets to 8 mM glucose and 15 μM 1-Azakenpaullone significantly reduced cells in G0/G1 phase and increased cells in S phase. Combined treatment of human islets with 8 mM glucose and 5 μM 1-Azakenpaullone significantly increased Ki-67+/insulin+ cells as compared with basal glucose[4]. After 2-week administration of 1-Azakenpaullone, a significant reduction in the levels of phosphorylated Akt GSK-3β, and cyclin D1 was observed in the islets of c-KitW/+ mice when compared to c-Kit+/+ mice[5]. |
| Concentration | Treated Time | Description | References | |
| Human fetal cortical neurons | 50, 100, 400 nM | 2-4 days | Enhanced KCC2 mRNA and protein expression | Nat Commun. 2021 Oct 27;12(1):6208. |
| Embryonic chick atrial myocytes | 2-5 µM | 24 hours | To investigate the inhibitory effect of Kenpaullone on GSK3β and its impact on SREBP-1 and GIRK4 expression. Results showed that Kenpaullone dose-dependently increased the expression of nSREBP-1 and GIRK4. | Diabetes. 2014 Jun;63(6):2097-113. |
| Islet cells | 10 µM | 24 hours | To evaluate the effect of 1-AKP on insulin secretion in islet cells. Results showed that islets from 1-AKP-treated c-KitWv/+ mice exhibited a significant increase in insulin secretion in response to 22 mM glucose, with a 2-fold increase compared to the untreated group. | Lab Invest. 2012 Apr;92(4):543-55. |
| HEK 293T cells | 5 µM | 24 hours | To investigate the effect of ubiquitination on PXR protein levels, results showed that MG-132 effectively stabilized PXR protein. | Cells. 2022 Jan 13;11(2):264. |
| HepG2 cells | 5 µM | 24 hours | To investigate the effect of CDK inhibitors on PXR protein levels, results showed that kenpaullone significantly increased PXR protein levels. | Cells. 2022 Jan 13;11(2):264. |
| RAW 264.7 macrophages | 150 nM | 24 hours | To investigate the effect of 1-Azakenpaullone on RANKL-induced NFATc1 nucleotranslocation, results showed that 1-Azakenpaullone significantly reversed the inhibitory effects of fucoidan on NFATc1 phosphorylation and nucleotranslocation. | Mar Drugs. 2019 Jun 10;17(6):345. |
| Primary cortical neurons | 0.25–2 µM | 36 hours | KEN enhanced ADAM10 protein levels | Adv Sci (Weinh). 2024 Mar;11(11):e2305260. |
| HT22 cells | 0.25–2 µM | 36 hours | KEN enhanced ADAM10 protein levels | Adv Sci (Weinh). 2024 Mar;11(11):e2305260. |
| HEK293 cells | 0.25–2 µM | 36 hours | KEN enhanced ADAM10 protein levels | Adv Sci (Weinh). 2024 Mar;11(11):e2305260. |
| Rat primary cortical neurons | 0.1 µM, 0.2 µM, 0.5 µM | 3 days | Enhanced Kcc2 mRNA expression in a dose-dependent manner | Nat Commun. 2021 Oct 27;12(1):6208. |
| SH-SY5Y cells | 0.25–2 µM | 36 hours | KEN significantly increased m-ADAM10 protein levels | Adv Sci (Weinh). 2024 Mar;11(11):e2305260. |
| Rat islet cells | 5, 10, 15 µM | 4 days | To assess DNA synthesis and cell cycle progression. Results showed that 1-Akp significantly increased DNA synthesis, which was sensitive to rapamycin. | Diabetes. 2009 Mar;58(3):663-72. |
| Human islet cells | 5, 10, 15 µM | 4 days | To assess DNA synthesis, cell cycle progression, and β-cell proliferation. Results showed that 1-Akp significantly enhanced DNA synthesis, which was sensitive to rapamycin. | Diabetes. 2009 Mar;58(3):663-72. |
| Adult human skin fibroblasts | 1 µM | starting at 14 dpi | Kenpaullone significantly promotes the survival of ALS-hiMNs, enhances dendritic outgrowth and branching, rescues soma size, completely normalizes excitability, and restores the ability to form NMJs and control muscle activity. | Cell Rep. 2016 Jan 5;14(1):115-128. |
| Administration | Dosage | Frequency | Description | References | ||
| Mice | Nerve constriction injury pain model and bone cancer pain model | Intraperitoneal and intrathecal injection | 10-30 mg/kg | Daily injections for 7-14 days | KP significantly alleviated neuropathic pain and bone cancer pain, and repaired Kcc2 expression deficits in the spinal cord dorsal horn | Nat Commun. 2021 Oct 27;12(1):6208. |
| Mice | C-KitWv/+ male mice | Intraperitoneal injection | 2mg/kg | Every other day for 2 weeks | To evaluate the effect of 1-AKP on glucose metabolism and β-cell function in c-KitWv/+ mice. Results showed that 1-AKP treatment significantly improved fasting blood glucose levels, glucose tolerance, and insulin secretion, and increased β-cell mass and proliferation in c-KitWv/+ mice. | Lab Invest. 2012 Apr;92(4):543-55. |
| Zebrafish | Zebrafish lateral-line neuromasts | Immersion | 30–50 µM | 20 hours | Evaluating the protective effect of kenpaullone against cisplatin-induced hair cell loss in zebrafish lateral-line neuromasts, results showed kenpaullone significantly reduced hair cell loss. | J Exp Med. 2018 Apr 2;215(4):1187-1203. |
| FVB mice | Cisplatin-induced ototoxicity model | Transtympanic injection | 50 μM | 1 hour before and 24 hours after cisplatin administration | Evaluated the protective effect of 1-Azakenpaullone against cisplatin-induced ototoxicity, showing significant reduction in hearing loss. | J Med Chem. 2018 Sep 13;61(17):7700-7709. |
| APP/PS1 mice | Alzheimer's disease model | Intraperitoneal injection | 7 mg/kg | Every other day for 2 months | KEN promoted ADAM10 expression and improved cognitive functions | Adv Sci (Weinh). 2024 Mar;11(11):e2305260. |
| 计算器 | ||||
| 存储液制备 | ![]() |
1mg | 5mg | 10mg |
|
1 mM 5 mM 10 mM |
3.05mL 0.61mL 0.30mL |
15.24mL 3.05mL 1.52mL |
30.47mL 6.09mL 3.05mL |
|
| CAS号 | 676596-65-9 |
| 分子式 | C15H10BrN3O |
| 分子量 | 328.16 |
| SMILES Code | BrC1=CC=C2C(C(CC(NC3=C4N=CC=C3)=O)=C4N2)=C1 |
| MDL No. | MFCD09037522 |
| 别名 | 1-Akp |
| 运输 | 蓝冰 |
| 存储条件 |
In solvent -20°C: 3-6个月 -80°C: 12个月 Pure form Sealed in dry, 2-8°C |
| 溶解方案 |
DMSO: 190 mg/mL(578.98 mM),配合低频超声助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO 以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶
|
沪公网安备 31011702889066号
沪ICP备2024050318号-1